For a better browsing experience and to benefit from all the features of credit-agricole.com, we advise you to use the Edge browser.
  • Text Size
  • Contrast

                                                                                                                                                 

 

Not to be transmitted, released, published or distributed, directly or indirectly, in the USA, Canada, Australia or Japan

 

 

 

Press release

 

Paris, on November 25 2015

 

 

 

Exercise of the over-allotment option in connection with Amundi’s initial public offering

 

3,779,010 shares sold by Credit Agricole S.A.

 

 

Crédit Agricole S.A. announces today the partial exercise of the over-allotment option granted to J.P. Morgan Securities plc, the stabilization agent, acting in the name and on behalf of the underwriters, in connection with Amundi’s initial public offering on the regulated market of Euronext in Paris, for a number of 3,779,010 existing shares sold by Crédit Agricole S.A., at the initial public offering price of €45.00 per share. The total gross proceeds from the exercise of the over-allotment option amount to approximately €170 million.
Following the exercise of the over-allotment option, Crédit Agricole Group remains Amundi’s majority shareholder, owning 75.7% of the share capital and voting rights1.

Press Contact
Louise Tingström +44 7899 066995

1 This number does not take into account the employee offering.

 

Information available to the public
Copies of the prospectus that has been granted visa number 15-552 by the AMF on October 30, 2015, consisting of a Document de base registered with the AMF under number of I.15-073 on October 6, 2015 and a Note d’opération (including a summary of the prospectus) are available on the websites of Amundi (www.amundi.com) and the AMF (www.amf-france.org), and free of charge upon request to Amundi at 91-93 boulevard Pasteur, 75015 Paris. Amundi draws the public’s attention to Chapter 4 “Risk Factors” of the Document de base and Section 2 of the Note d’opération “Risk Factors related to the Global Offering”. One or more of these risks, should they materialize, could have a material adverse effect on the Amundi group’s activities, assets, financial position, results or prospects, as well as on the market price of Amundi shares.

Disclaimer :

This announcement does not, and shall not, in any circumstances constitute a public offering or an offer to subscribe shares nor an invitation to the public in connection with any public offering.
No communication or other information related to this transaction or to Amundi may be distributed to the public in any jurisdiction where approval or registration is required. No steps have been or will be taken by the company in any country (other than France) where such steps would be required. The subscription for or the purchase of Amundi shares may be subject to specific legal or regulatory restrictions in certain jurisdictions. Amundi assumes no responsibility for any violation of any such restrictions by any person.

This press release does not constitute a prospectus within the meaning of Directive 2003/71/CE of the European Parliament and Council dated November 4, 2003, to the extent implemented in the relevant member states of the European Economic Area (together, the “Prospectus Directive”).

This press release is an advertisement.

In France, an offer of securities to the public may only be made pursuant to a prospectus which has received an AMF visa. With respect to the member states of the European Economic Area other than France (the “Member States”) having implemented the Prospectus Directive into law, no action has been or will be taken in order to permit a public offer of the securities which would require the publication of a prospectus in one of such Member States. Consequently, the securities cannot be offered and will not be offered in any Member State (other than France), except in accordance with the exemptions set out in Article 3(2) of the Prospectus Directive, if they have been implemented in the relevant Member State(s) or in the other cases which do not require the publication by Amundi of a prospectus pursuant to the Prospectus Directive and/or applicable regulation in the Member States.

The distribution of this press release is not made, and has not been approved, by an “authorized person” within the meaning of Article 21(1) of the Financial Services and Markets Act 2000. As a consequence, this press release is addressed to and directed only at persons who (i) are located outside the United Kingdom, (ii) have professional experience in matters relating to investments within the meaning of Article 19(5) (“investment professionals”) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005, (iii) are persons falling within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 or (iv) are persons to whom this press release may otherwise lawfully be communicated (all such persons together being referred to as “Relevant Persons”). The securities of Amundi are directed only at Relevant Persons and no invitation, offer or agreement to subscribe, purchase or otherwise acquire the securities of Amundi may be proposed or made other than with Relevant Persons. Any person other than a Relevant Person may not act or rely on this document or any provision thereof. This press release is not a prospectus which has been approved by the Financial Services Authority or any other United Kingdom regulatory authority for the purposes of Section 85 of the Financial Services and Markets Act 2000.

These materials are not an offer for sale of Amundi shares in the United States or in any other jurisdiction. Amundi shares may not be sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. Amundi does not intend to register in the United States any portion of the offering or to conduct a public offering of the shares in the United States.

Circulation of this press release in certain countries may result in a violation of applicable law. The information contained in this document does not constitute an offer of securities for sale in Canada, Australia or Japan. This press release should not be published, circulated or distributed, directly or indirectly, within the United States, Canada, Australia or Japan.

 

Follow info

If you wish to exercise your right to object to the processing of personal data for audience measurement purposes on our site via our service provider AT internet, click on refuse